Citadel Advisors - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$350,339
+67.9%
1,072,712
+131.3%
0.00%
Q4 2022$208,701
-3.4%
463,780
+89.2%
0.00%
Q3 2022$216,000
-40.0%
245,115
-21.8%
0.00%
Q2 2022$360,000
-75.5%
313,262
-62.7%
0.00%
Q1 2022$1,470,000
+54.2%
839,877
+185.8%
0.00%
Q4 2021$953,000
+958.9%
293,911
+1210.9%
0.00%
Q3 2021$90,000
+69.8%
22,421
-30.4%
0.00%
Q2 2021$53,00032,2190.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 900,733$1,883,0001.44%
Sio Capital Management, LLC 1,501,998$3,139,0000.92%
CVI Holdings, LLC 704,900$1,473,0000.55%
Perceptive Advisors 8,476,496$17,466,0000.28%
Artal Group S.A. 2,974,000$6,216,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 880,000$1,839,0000.17%
DAFNA Capital Management LLC 275,000$575,0000.17%
J. Goldman & Co LP 1,018,285$2,128,0000.13%
MYDA Advisors LLC 100,000$209,0000.13%
683 Capital Management, LLC 526,466$1,100,0000.09%
View complete list of LEAP THERAPEUTICS INC shareholders